MedTrace Logo

Prognostic Impact of an Oral Triglyceride Tolerance Test in Patients After Acute Ischemic Stroke

NCT01378468 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 573

Last updated 2017-01-31

No results posted yet for this study

Summary

Non-fasting triglyceride levels are thought to play a role in stroke. The investigators hypothesise that the results of a standardised oral triglyceride tolerance test in the subacute setting (3-7 days) after the first ischaemic stroke are associated with the risk of recurrent stroke within 12 months after the index event.

Conditions

  • First Ischemic Stroke

Interventions

OTHER

oral triglyceride tolerance test (not a therapeutic "intervention" as such but a new diagnostic test)

see Ebinger et al., IJS, 2010

Sponsors & Collaborators

  • University Hospital, Saarland

    collaborator OTHER

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Martin Ebinger · CSB

  • Matthias Endres · CSB

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2016-07-31
Completion
2017-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01378468 on ClinicalTrials.gov